CB-010 Shows Promise for B-Cell Non-Hodgkin Lymphoma, Study Shows

Recent results are available from the dose escalation portion of the Phase 1 ANTLER study. In reporting from Targeted Oncology, Jordyn Sava shares that the study included 16 participants living…

Continue Reading CB-010 Shows Promise for B-Cell Non-Hodgkin Lymphoma, Study Shows